Ana B. C.
- Country
- Sweden
- Department
- Department of Hematology, Oncology and Radiotherapy
Research Overview
Data & Insights
Has run more than one trial at 0 of 64 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in the treatment of advanced and metastatic breast cancer, with particular emphasis on hormone receptor-positive (HR+) and HER2-negative disease states.
- Advanced Breast Cancer Therapeutics
- Hormone Receptor-Positive Disease Management
- Metastatic Disease Treatment
Focuses on developing therapeutic strategies for locally advanced and unresectable breast cancer conditions.
Targeted Therapy Approaches
Conducts research in combination therapy approaches, investigating novel therapeutic agents in conjunction with established treatments such as fulvestrant.
- Combination Treatment Strategies
- Novel Therapeutic Agents
- Treatment Response Assessment
Evaluates innovative therapeutic combinations for breast cancer treatment optimization.
Treatment Response Studies
Investigates response-guided treatment approaches in various breast cancer subtypes, including both primary breast cancer and advanced disease states.
- Objective Response Evaluation
- Long-term Outcome Assessment
- Preoperative Treatment Strategies
Explores the effectiveness of personalized treatment approaches based on patient response patterns.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.